WHO Grade 1 Glioma
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma (NCT04166409) | National Cancer Institute (NCI) | 2020-01-31 |
Track WHO Grade 1 Glioma automatically
Every clearance here is in the API, with alerts when new ones post.